Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	201.36	-472.63	156.83
Graham Fair Price	1121.83	0.78	0.06
PEG	-100.00	< 0.005	55.52
Price/Book	-10.88	2.18	2.45
Price/Cash Flow	70.81	-14.13	8.27
Prices/Earnings	99.40	-34.42	-5737.27
Price/Sales	63.07	3.53	2.16
Price/FCF	70.81	-14.13	8.27
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-19.71	0.10	0.12
Operating Margin	-948.76	-0.03	< 0.005
ROA	-15904.65	< 0.005	< 0.005
ROE	< 0.005	-0.02	-14754.90
ROIC	< 0.005	< 0.005	-1587.86
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.01	-0.07	82.45
Dividends QOQ	-0.30	-0.04	85.90
EBIT QOQ	-2.78	-4.76	-71.35
EPS QOQ	-1.03	-206.00	-19835.48
FCF QOQ	6.04	-1.52	-74.77
Revenue QOQ	0.28	-0.45	62.98
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	31.19	69.50	122.80
Days Sales Outstanding (DSO)	132.59	212.72	60.43
Inventory Turnover	2.89	1.29	-55.12
Debt/Capitalization	0.54	0.53	-0.77
Quick Ratio	0.94	0.86	-7.71
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.30	1.31	0.25
Cash	0.72	0.47	-34.30
Capex	-0.02	-0.03	-18.54
Free Cash Flow	0.39	-0.20	-47.70
Revenue	1.47	0.81	-45.21
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.10	1.11	0.69
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	30.25	-124.27	310.76
Naive Interpretation	Member

06 - Financial Health · Bad

Rating